CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading-Reference-Cited by-同舟云学术

CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading

Published:2018-04-24 Issue:1 Volume:16 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Chu Xin,Jin Qunyan,Chen Hui,Wood G. Craig,Petrick Anthony,Strodel William,Gabrielsen Jon,Benotti Peter,Mirshahi Tooraj,Carey David J.,Still Christopher D.,DiStefano Johanna K.,Gerhard Glenn S.^ORCID

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-018-1490-y.pdf

Reference49 articles.

1. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199–210.

2. Gluchowski NL, Becuwe M, Walther TC, Farese RV Jr. Lipid droplets and liver disease: from basic biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2017;14(6):343–55.

3. Basaranoglu M, Basaranoglu G, Senturk H. From fatty liver to fibrosis: a tale of “second hit”. World J Gastroenterol. 2013;19(8):1158–65.

4. Tariq Z, Green CJ, Hodson L. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)? Liver Int. 2014;34(7):e180–90.

5. Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577–94.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding;Frontiers in Endocrinology;2024-07-04

2. Senescence-associated secretory phenotype (SASP) and uterine fibroids: Association with PD-L1 activation and collagen deposition;Ageing Research Reviews;2024-06

3. Roles and therapeutic targeting of dendritic cells in liver fibrosis;Journal of Drug Targeting;2024-04-29

4. CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B;Heliyon;2024-04

5. Identification and validation of hub genes expressed in ulcerative colitis with metabolic dysfunction-associated steatotic liver disease;Frontiers in Immunology;2024-03-14